Skip to main content
. Author manuscript; available in PMC: 2017 Jul 7.
Published in final edited form as: Int J Cancer. 2016 Nov 15;139(10):2178–2192. doi: 10.1002/ijc.30281

Table 9.

Cox proportional hazards model of time to lung cancer mortality according to amount of current (study entry) total physical activity (MET-min/wk) by lung cancer subtype

MET minutes per week No. of cases Unadjusted model
Adjusted model*
HR (95% CI) Global p values HR (95% CI) Global p values
NSCLC subtype

0 to <100 269 Ref. 0.0001 Ref. 0.02

100 to <500 256 0.92 (0.77–1.09) 0.98 (0.82–1.16)

500 to <1,200 217 0.72 (0.60–0.86) 0.80 (0.66–0.98)

1,200+ 179 0.70 (0.58–0.85) 0.76 (0.62–0.94)

SCLC subtype

0 to <100 51 Ref. 0.55 Ref. 0.46

100 to <500 38 0.93 (0.61–1.42) 1.10 (0.61–1.99)

500 to <1,200 31 0.73 (0.47–1.15) 0.68 (0.38–1.25)

1,200+ 32 0.99 (0.63–1.54) 0.99 (0.56–1.76)

NSCLC-squamous

0 to <100 44 Ref. 0.15 Ref. 0.07

100 to <500 44 1.02 (0.67–1.55) 0.96 (0.56–1.64)

500 to <1,200 26 0.61 (0.37–0.99) 0.57 (0.31–1.03)

1,200+ 22 0.81 (0.49–1.36) 0.52 (0.26–1.04)

NSCLC-adenocarcinoma

0 to <100 126 Ref. 0.0008 Ref. 0.02

100 to <500 108 0.75 (0.58–0.97) 0.81 (0.62–1.07)

500 to <1,200 115 0.66 (0.52–0.86) 0.72 (0.54–0.96)

1,200+ 99 0.60 (0.46–0.79) 0.64 (0.48–0.87)

NSCLC-other

0 to <100 101 Ref. 0.42 Ref. 0.23

100 to <500 105 1.22 (0.92–1.60) 1.37 (1.01–1.85)

500 to <1,200 78 0.98 (0.72–1.32) 1.15 (0.80–1.64)

1,200+ 60 1.10 (0.80–1.52) 1.13 (0.78–1.66)
HHS Vulnerability Disclosure